An injectable active hydrogel based on BMSC-derived extracellular matrix for cartilage regeneration enhancement

Biomater Adv. 2024 Jun:160:213857. doi: 10.1016/j.bioadv.2024.213857. Epub 2024 Apr 12.

Abstract

Articular cartilage injury impairs joint function and necessitates orthopedic intervention to restore the structure and function of the cartilage. Extracellular matrix (ECM) scaffolds derived from bone marrow mesenchymal stem cells (BMSCs) can effectively promote cell adhesion, proliferation, and chondrogenesis. However, pre-shaped ECM scaffolds have limited applicability due to their poor fit with the irregular surface of most articular cartilage defects. In this study, we fabricated an injectable active ECM hydrogel from autologous BMSCs-derived ECM by freeze-drying, liquid nitrogen milling, and enzymatic digestion. Moreover, our in vitro and in vivo results demonstrated that the prepared hydrogel enhanced chondrocyte adhesion and proliferation, chondrogenesis, cartilage regeneration, and integration with host tissue, respectively. These findings indicate that active ECM components can provide trophic support for cell proliferation and differentiation, restoring the structure and function of damaged cartilage.

Keywords: Active hydrogel; Autologous; Cartilage regeneration; Extracellular matrix; Injectable.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cartilage, Articular* / injuries
  • Cartilage, Articular* / physiology
  • Cell Adhesion
  • Cell Differentiation
  • Cell Proliferation
  • Chondrocytes* / transplantation
  • Chondrogenesis*
  • Extracellular Matrix* / chemistry
  • Extracellular Matrix* / metabolism
  • Humans
  • Hydrogels* / chemistry
  • Injections
  • Mesenchymal Stem Cells* / cytology
  • Rabbits
  • Regeneration*
  • Tissue Engineering* / methods
  • Tissue Scaffolds* / chemistry

Substances

  • Hydrogels